Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI

NCT02658838 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT02658838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02658838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI
Lead sponsor
Beijing Anzhen Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2015
Completion date
September 30, 2017
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lovastatin/ticagrelor [va drug interaction]